Astrana Health Inc. (ASTH) is a Professional Services company listed on NASDAQ. In the last 30 days Quantisnow tracked 7 wire items for ASTH, including 3 insider trades, 2 earnings updates and 1 press release or news item. The most recent was published Nov 5, 2026.
ASTH rankings
Financial highlights
Full financials- Revenue, TTM
- $3.84B
- Revenue growth
- +58.9%
- Net income, TTM
- $40.55M
- Net margin
- 1.1%
- Free cash flow, TTM
- $94.38M
- Cash
- $400.79M
For the twelve months ended Jun 30, 2026, from SEC filings. Not investment advice.
News · 26 weeks42-70%
2026-05-102026-11-01
Mix2090d
- Insider11(55%)
- SEC Filings5(25%)
- Earnings2(10%)
- Analyst1(5%)
- Other1(5%)
Latest news
25 items- SECAstrana Health Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits8-K - Astrana Health, Inc. (0001083446) (Filer)
- PRAstrana Health, Inc. Reports Third Quarter 2026 ResultsCompany to Host Conference Call on Thursday, November 5, 2026, at 2:30 p.m. PT/5:30 p.m. ETReports record revenue of $1,023.6 million, up 7% year-over-year, net income of $20.3 million, up 1,782% year-over-year, and record adjusted EBITDA(1) of $77.2 million, up 13% year-over-year for the three months ended September 30, 2026 Reports net cash provided by operating activities of $117.1 million and free cash flow(2) of $105.4 million for the nine months ended September 30, 2026ALHAMBRA, Calif., Nov. 5, 2026 /PRNewswire/ -- Astrana Health, Inc. ("Astrana," and together with its subsidiaries and affiliated entities, the "Company") (NASDAQ:ASTH), a physician-centric, technology-enabled healthcare
- INSIDERSEC Form 4 filed by Astrana Health Inc.4 - Astrana Health, Inc. (0001083446) (Issuer)
- PRVerda Healthcare, Inc. and AstranaCare Partners Form a Multi-State PartnershipVerda Healthcare, Inc. is proud to announce a new partnership with AstranaCare Partners of Arizona and AstranaCare Partners of Texas. AstranaCare, through a large network of Independent Physician Associations (IPAs), enables providers to deliver high-quality care, efficiently with supportive local resources and technology tools that allow providers to focus more on patient care rather than administrative tasks. Astrana Health, the parent company, has over 20,000 in-network providers and manages over 1.6 million lives. This alliance extends to Arizona and Texas, signifying a significant step forward in advancing the quality and accessibility of healthcare in underserved communities across th
- PRAstrana Health, Inc. Schedules 2026 Third Quarter Financial Results Release and Conference CallALHAMBRA, Calif., Oct. 9, 2026 /PRNewswire/ -- Astrana Health, Inc. ("Astrana," and together with its subsidiaries and affiliated entities, the "Company") (NASDAQ:ASTH), a physician-centric, technology-enabled healthcare company empowering providers to deliver accessible, high-quality, and high-value care to all, today announced that it will release financial results for the third quarter ended September 30, 2026, after the close of the stock market on Thursday, November 5, 2026. The Company will discuss those results on a conference call at 2:30 p.m. PT/5:30 p.m. ET that same day.Participant Dial-in Numbers: 877-858-9810 / +1 201-689-8517To access the call, please dial in approximately five
- INSIDERSEC Form 4 filed by Astrana Health Inc.4 - Astrana Health, Inc. (0001083446) (Issuer)
- INSIDERSEC Form 4 filed by Astrana Health Inc.4 - Astrana Health, Inc. (0001083446) (Issuer)
- INSIDERSEC Form 4 filed by Astrana Health Inc.4 - Astrana Health, Inc. (0001083446) (Issuer)
- SECAstrana Health Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits8-K - Astrana Health, Inc. (0001083446) (Filer)
- SECSEC Form 8-K filed by Astrana Health Inc.8-K - Astrana Health, Inc. (0001083446) (Filer)
- INSIDERSVP - Accounting (PAO) Vong John covered exercise/tax liability with 96 shares, decreasing direct ownership by 0.43% to 22,330 units (SEC Form 4) to satisfy withholding tax4 - Astrana Health, Inc. (0001083446) (Issuer)
- ANALYSTOppenheimer initiated coverage on Astrana Health with a new price targetOppenheimer initiated coverage of Astrana Health with a rating of Outperform and set a new price target of $53.00
- SECAstrana Health Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits8-K - Astrana Health, Inc. (0001083446) (Filer)
- INSIDERCEO and President Sim Brandon covered exercise/tax liability with 7,163 shares, decreasing direct ownership by 0.57% to 1,238,861 units (SEC Form 4) to cover withholding tax4 - Astrana Health, Inc. (0001083446) (Issuer)
- INSIDERCOO and CFO Basho Chandan covered exercise/tax liability with 1,790 shares, decreasing direct ownership by 1% to 157,820 units (SEC Form 4) (for tax liability)4 - Astrana Health, Inc. (0001083446) (Issuer)
- INSIDERDirector Kitayama Mitchell W returned $315,265 worth of shares to the company (8,500 units at $37.09), decreasing direct ownership by 26% to 24,337 units (SEC Form 4)4 - Astrana Health, Inc. (0001083446) (Issuer)
- INSIDERDirector Schmidt David exercised 20,000 shares at a strike of $5.00 and returned $771,800 worth of shares to the company (20,000 units at $38.59) (SEC Form 4)4 - Astrana Health, Inc. (0001083446) (Issuer)
- INSIDERNew insider Vong John claimed ownership of 22,426 shares (SEC Form 3)3 - Astrana Health, Inc. (0001083446) (Issuer)
- INSIDERFormer Officer Sobotka Glenn returned 11,793 shares to the company, decreasing direct ownership by 84% to 2,246 units (SEC Form 4)4 - Astrana Health, Inc. (0001083446) (Issuer)
- SECSEC Form 10-Q filed by Astrana Health Inc.10-Q - Astrana Health, Inc. (0001083446) (Filer)
- SECAstrana Health Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits8-K - Astrana Health, Inc. (0001083446) (Filer)
- PRAstrana Health, Inc. Reports Second Quarter 2026 ResultsCompany to Host Conference Call on Thursday, August 6, 2026, at 2:30 p.m. PT/5:30 p.m. ETReports revenue of $972.5 million, up 49% year-over-year, net income of $18.5 million, up 81% year-over-year, and adjusted EBITDA (1) of $68.9 million, up 43% year-over-year for the three months ended June 30, 2026Reports net cash provided by operating activities of $100.8 million and free cash flow (2) of $92.9 million for the six months ended June 30, 2026ALHAMBRA, Calif., Aug. 6, 2026 /PRNewswire/ -- Astrana Health, Inc. ("Astrana," and together with its subsidiaries and affiliated entities, the "Company") (NASDAQ:ASTH), a physician-centric, technology-enabled healthcare company empowering providers t
- PRAstrana Health, Inc. Schedules 2026 Second Quarter Financial Results Release and Conference CallALHAMBRA, Calif., July 14, 2026 /PRNewswire/ -- Astrana Health, Inc. ("Astrana," and together with its subsidiaries and affiliated entities, the "Company") (NASDAQ:ASTH), a physician-centric, technology-enabled healthcare company empowering providers to deliver accessible, high-quality, and high-value care to all, today announced that it will release financial results for the second quarter ended June 30, 2026, after the close of the stock market on Thursday, August 6, 2026. The Company will discuss those results on a conference call at 2:30 p.m. PT/5:30 p.m. ET that same day. Participant Dial-in Numbers: 877-858-9810 / +1 201-
- PRAstrana Health Strengthens Leadership Team to Accelerate Long-Term GrowthNames Daniel Rothman President of Physician Enterprise and Vishal Gupta Senior Vice President of Enterprise TransformationALHAMBRA, Calif., July 13, 2026 /PRNewswire/ -- Astrana Health, Inc. ("Astrana," and together with its subsidiaries and affiliated entities, the "Company") (NASDAQ:ASTH), a physician-centric, technology-enabled healthcare company empowering providers to deliver accessible, high-quality, and high-value care to all, today announced the appointments of Daniel Rothman as President of Physician Enterprise and Vishal Gupta as Senior Vice President of Enterprise Transformation. These additions further deepen Astran
- SECAstrana Health Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits8-K - Astrana Health, Inc. (0001083446) (Filer)
ASTH FAQ
9 questionsWhat is the latest news on ASTH?
In the last 30 days Quantisnow tracked 7 wire items for ASTH: 3 insider trades, 2 earnings updates, 1 press release or news item and 1 SEC filing. The most recent was published on November 5, 2026.What is ASTH revenue?
Astrana Health Inc. (ASTH) reported $3.84B of revenue for the twelve months ended Jun 30, 2026. That is up 58.9% from the year before. Revenue for fiscal 2025 was $3.18B.Is ASTH profitable?
Yes. Astrana Health Inc. earned $40.55M in net income for the twelve months ended Jun 30, 2026, a net margin of 1.1%.How much cash and debt does ASTH have?
Astrana Health Inc. reported $400.79M in cash and cash equivalents and $936.50M of debt on its most recent balance sheet in SEC filings.Where does ASTH stock trade?
Astrana Health Inc. (ASTH) is listed on NASDAQ.What sector and industry is ASTH in?
Astrana Health Inc. operates in the Consumer Discretionary sector, Professional Services industry.What are analysts saying about ASTH?
Across the last 8 analyst actions on Astrana Health Inc., there were 2 upgrades and 0 downgrades. The most recent action was from Oppenheimer: Outperform with a $53.00 price target on 2026-09-15. Recent price targets range from $28.00 to $66.00.What companies are similar to ASTH?
Notable peers in the same industry include GIB (CGI Inc.), BAH (Booz Allen Hamilton Holding Corporation), G (Genpact Limited), FCN (FTI Consulting Inc.), RHI (Robert Half Inc.). Compare ASTH side-by-side with any of them on Quantisnow.How can I track ASTH on Quantisnow?
Quantisnow aggregates Astrana Health Inc.'s SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow ASTH to receive live email and push alerts on every new disclosure.